基于FAERS数据库的数据挖掘和对Vedolizumab不良事件的分析
Qinyun Xu1, Jing Zhang1, Weihong Tang1
1Nanjing University of Chinese Medicine Wuxi Affiliated Hospital: Wuxi Hospital of Traditional Chinese Medicine, Wuxi, 214071, China.
Scientific reports
|January 2, 2025
概括
这项研究分析了对Vedolizumab的46,726份不良事件报告,确定了新的安全信号,如怀孕和Clostridium difficile感染,突出了这种向治疗的潜在系统性影响.
科学领域:
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
- 临床药理学 临床药理学
背景情况:
- 维多利祖马布是针对炎症性肠道疾病的向治疗.
- 了解现实世界的不良事件 (AE) 对患者安全至关重要.
- FAERS数据库提供了广泛的AE报告,用于药物安全性分析.
研究的目的:
- 使用FAERS数据库挖掘和分析与维多利祖马布相关的AE.
- 识别潜在的新安全信号,了解维多利祖马布的风险概况.
- 评估Vedolizumab在患有炎症性肠道疾病的患者中的实际安全性.
主要方法:
- 从FAERS数据库中利用了2014年第二季度到2023年第三季度的数据.
- 采用的信号挖掘技术:报告几率比率 (ROR),比例报告比率 (PRR),贝叶斯信心传播神经网络 (BCPNN) 和经验贝叶斯几何平均值 (EBGM).
- 分析了46726份与vedolizumab相关的AE报告,在27个器官系统类 (SOC) 中确定了401个首选术语 (PT).
主要成果:
- 确定了维多利祖马布AE报告的增加趋势,主要来自成年女性.
- 检测到新的潜在AE信号,包括怀孕,血病和Clostridium difficile感染.
- 观察到较少发生的AE的强烈信号,例如切口,肠感染和解剖学并发症.
结论:
- 维多利祖马布具有超出其目标作用的已识别的潜在风险的安全概况.
- 新的AE信号需要进一步调查,以确保患者的安全.
- 即使是像Vedolizumab这样的向疗法也可能产生意想不到的全身效应.
相关概念视频
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...